Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

China Biologic Closes Qianfeng Acquisition

publication date: Apr 17, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

China Biologic Products has obtained control of fellow China plasma products company Qianfeng Biological Products Co., Ltd. The closing makes China Biologic the country’s largest non-state owned enterprise in the plasma products sector. In 2008 Qianfeng had a 7.4% share of China’s plasma products market, while China Biologic held a 6.9% share. Together, they represent 14.3% of the market. More details...

Stock Symbol: (OTCBB: CBPO)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...